These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9280455)

  • 21. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
    St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
    Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
    Muroyama A; Inaka M; Matsushima H; Sugino H; Marunaka Y; Mitsumoto Y
    Neurosci Res; 2009 Jan; 63(1):72-5. PubMed ID: 18977253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
    Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
    J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K; Ferger B
    Neuroscience; 2009 Mar; 159(1):16-20. PubMed ID: 19146929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gas chromatography/mass spectrometric identification of dopaminergic metabolites in striata of rats treated with L-DOPA.
    Loutelier-Bourhis C; Legros H; Bonnet JJ; Costentin J; Lange CM
    Rapid Commun Mass Spectrom; 2004; 18(5):571-6. PubMed ID: 14978802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
    Rothblat DS; Schneider JS
    Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
    Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
    Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restorative effects of glutamate antagonists in experimental parkinsonism.
    Archer T; Palomo T; Fredriksson A
    Amino Acids; 2002; 23(1-3):71-85. PubMed ID: 12373521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N; Martín AB; Mendialdua A; Moratalla R
    Biol Psychiatry; 2006 Jan; 59(1):64-74. PubMed ID: 16139809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
    Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
    J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel sites of action for deprenyl in MPTP-parkinsonism: metabolite-mediated protection against striatal neurotoxicity and suppression of MPTP-induced increase of dopamine turnover in C57BL mice.
    Sziráki I; Kardos V; Patthy M; Gaál J; Arányi P; Kollár E; Tömösközi Z; Király I
    Prog Brain Res; 1995; 106():155-71. PubMed ID: 8584651
    [No Abstract]   [Full Text] [Related]  

  • 40. Excitatory amino acids and MPTP toxicity.
    Fornai F; Vaglini F; Maggio R; Bonuccelli U; Corsini GU
    Adv Neurol; 1996; 69():167-76. PubMed ID: 8615126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.